Rabia Nagda, MD, of Texas Children’s Pediatrics, emphasizes that every environment where kids spend time should be built with fall risk in mind.
Confluence Health’s transitional care program enlists semi-retired and retired doctors to cut wait times, improve follow-up care and support care teams.
Find out how to participate in the CPT process by attending an Editorial Panel meeting or applying for a new or updated CPT code.
VeriCre™ helps overcome one of the most consequential challenges in the credentialing process—receiving verified data in applications quickly and reliably
The AMA backs bipartisan legislation to reissue 40,000 unused immigrant visas for physicians and nurses.
Giving feedback that harnesses surgical residents’ thirst for improvement is a winner at Geisinger. The approach is spreading to other specialties.
Find information about the responsibilities and terms of service for the Government Relations Advocacy Fellow (GRAF) and how to apply.
Medical students at Geisinger Commonwealth School of Medicine have a special chance to ease debt burdens and meet rural health needs. Find out how.
In residency and fellowship training, the business side of medicine often gets short shrift. Catch up on what you need to succeed in health care.
ACGME-required midyear reviews shouldn’t be taken for granted. The feedback might sting, but this is your chance to drill down for specifics.
Stay up to date on OBBBA implementation and related federal rulemaking with resources from the AMA.
Supporting the Improving Seniors’ Timely Access to Care Act, details on the FDA TEMPO model and more in the latest National Advocacy Update.
ChangeMedEd® is a national bi-annual conference that brings together innovative leaders across the medical education continuum to reimagine the way future physicians are trained. Learn more.
This two-day boot camp, April 13-14, 2026, will equip attendees with the time-saving tools and strategies to reform their organizations and enhance professional satisfaction.
Find out about the election bylaws and policies for being elected to the AMA House of Delegates.
Find out about opportunities for representation of Federation organizations in the AMA sections' annual and interim meetings.
Download PDFs of reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
Recap of the joint CME education event at I-25 and a review of the strategic goals for 2025-26.
Read current and past issues of WPS Members & News Highlights for the latest information on the work being done by WPS members and its leadership.
In the news: Changes to federal vaccine recommendations, GLP-1s and obesity-related cancer risk, uterine fibroids may raise heart disease risk and more.
Review a list of USAN Council-approved stems and which chemical and/or pharmacologic parameters have been established.
Substance misuse affects millions of Americans every year. The AMA is committed to addressing the root causes of substance misuse in America.
When it comes to the comprehensive management for chronic pain, recognize that patients with a history of alcoholism or substance use disorder are at higher risk for abuse, and should be managed very carefully.
Team-based care, fighting opioid epidemic, managed care, and public health are among the 4 top issues for medical associations and policymakers as state legislatures convene for the new year.
The AMA today released comments on the Centers for Disease Control and Prevention's (CDC) proposed opioid prescription policy.
The AMA identified 9 top developments in health care regulations, legislation and insurance to watch in 2016. Included are: Medicare reforms, provider networks, and graduate medical education funding.
A panel of experts offered ways physicians could help end the opioid overdose epidemic and improve patient care. Among the suggestions were rethinking prescribing practices and the effective use of PDMPs.
The Food and Drug Administration has approved a nasal spray version of naloxone—the medication that can reverse the effects of an opioid overdose and save thousands of lives by restoring breathing and preventing death. The approval marks another gain in the effort to curb the opioid overdose epidemic.
The AMA praises the FDA for approving the nasal spray version of naloxone, a medication that can reverse effects of an opioid overdose by restoring breathing.
The 2015 AMA Interim Meeting took place this week. Read these highlights from the meeting, and see AMA Wire's® full coverage of the event to learn more.
In response to increasing drug costs impacting patient access to needed medications, physicians voted Monday at the 2015 Interim Meeting to convene a task force and launch an advocacy campaign to drive solutions and help make prescription drugs more affordable. Physicians also are calling for greater competition in the pharmaceutical industry and transparency in prescription drug prices and costs.
